BN Business News
Add your company to Business Communicator →

Business · 13/06/2003Updated: 10/17/2026 · 1 min read

FDA Amends Regulation for Over-the-Counter Skin Protectant Astringent Drug Products

Summary

The FDA is revising labeling for over-the-counter skin protectant astringent drug products to align with the 2003 final rule and adding labeling for small packages like styptic pencils. This action is part of the FDA's ongoing review of OTC drug products.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →